Avestar Capital’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Avestar Capital’s Portfolio BTAL Stock Details BTAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$885K	Sell	79,403 -5,625	-7%	-$68.4K	0.05%	270
2026 Q1	$1.19M	Sell	85,028 -5,093	-6%	-$71.4K	0.08%	191
2025 Q4	$1.31M	Sell	90,121 -31,569	-26%	-$475K	0.08%	181
2025 Q3	$1.94M	Sell	121,690 -10,035	-8%	-$165K	0.13%	135
2025 Q2	$2.33M	Sell	131,725 -4,418	-3%	-$86.1K	0.16%	106
2025 Q1	$2.84M	Sell	136,143 -32,148	-19%	-$610K	0.25%	78
2024 Q4	$3.21M	Sell	168,291 -3,039	-2%	-$58.5K	0.27%	70
2024 Q3	$3.36M	Sell	171,330 -5,540	-3%	-$110K	0.35%	59
2024 Q2	$3.47M	Buy	176,870 +38,874	+28%	+$737K	0.36%	59
2024 Q1	$2.49M	Sell	137,996 -133,756	-49%	-$2.43M	0.26%	71
2023 Q4	$4.89M	Buy	271,752 +56,177	+26%	+$1.12M	0.55%	38
2023 Q3	$4.28M	Buy	+215,575	New	+$4.08M	0.61%	43

Other funds holding BTAL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

CCA

Carrera Capital Advisors Troy, Michigan $675M AUM 17.92% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

Avestar Capital's BTAL Position: Q2 2026 in Review

Avestar Capital reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 6.6% in Q2 2026, selling an estimated $68.4K and leaving 79,403 shares worth $885K. The position accounts for 0.05% of the portfolio, ranked #270.

Avestar Capital first reported a position in BTAL in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.89M in Q4 2023. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

Avestar Capital held 79,403 shares of AGF US Market Neutral Anti-Beta Fund worth $885K as of Q2 2026.
Avestar Capital sold 5,625 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $68.4K.
AGF US Market Neutral Anti-Beta Fund made up 0.05% of Avestar Capital's portfolio in Q2 2026, its #270 holding.
Avestar Capital first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2023 and has held it in 12 quarters since.
Avestar Capital's AGF US Market Neutral Anti-Beta Fund position peaked at $4.89M in Q4 2023.
93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.